Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $48,277 - $67,387
50,289 New
50,289 $51,000
Q2 2022

Aug 09, 2022

BUY
$0.94 - $1.94 $51,882 - $107,076
55,194 Added 168.39%
87,972 $90,000
Q1 2022

May 13, 2022

BUY
$1.54 - $3.71 $50,478 - $121,606
32,778 New
32,778 $64,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $610M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.